TY - JOUR AU - Smith, T. J. AU - Hillner, B. E. PY - 2011 DA - 2011// TI - Bending the Cost Curve in Cancer Care JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMsb1013826 DO - 10.1056/NEJMsb1013826 ID - Smith2011 ER - TY - JOUR AU - Bach, P. B. PY - 2009 DA - 2009// TI - Limits on Medicare’s Ability to Control Rising Spending on Cancer Drugs JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMhpr0807774 DO - 10.1056/NEJMhpr0807774 ID - Bach2009 ER - TY - JOUR AU - Meropol, N. J. AU - Schulman, K. A. PY - 2007 DA - 2007// TI - Cost of cancer care: issues and implications JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.6081 DO - 10.1200/JCO.2006.09.6081 ID - Meropol2007 ER - TY - STD TI - CBS-International comparisons, Israel 2008 http://www.cbs.gov.il. Accessed 21 Aug 2016. UR - http://www.cbs.gov.il/ ID - ref4 ER - TY - JOUR AU - Walley, T. AU - Folino-Gallo, P. AU - Stephens, P. AU - Ganse, E. PY - 2005 DA - 2005// TI - Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003 JO - Br J Clin Pharmacol VL - 60 UR - https://doi.org/10.1111/j.1365-2125.2005.02478.x DO - 10.1111/j.1365-2125.2005.02478.x ID - Walley2005 ER - TY - STD TI - Ministry of Health website, Cancer incidence table, Invasive tumors only. http://www.health.gov.il/UnitsOffice/HD/ICDC/ICR/CancerIncidence/Pages/All_sites_inv.aspx. Accessed 21 Aug 2016. UR - http://www.health.gov.il/UnitsOffice/HD/ICDC/ICR/CancerIncidence/Pages/All_sites_inv.aspx ID - ref6 ER - TY - JOUR AU - Rochau, U. AU - Sroczynski, G. AU - Wolf, D. AU - Schmidt, S. AU - Jahn, B. AU - Kluibenschaedl, M. AU - Conrads-Frank, A. AU - Stenehjem, D. AU - Brixner, D. AU - Radich, J. AU - Gastl, G. AU - Siebert, U. PY - 2014 DA - 2014// TI - Cost-Effectiveness of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia JO - Leuk Lymphoma VL - 13 ID - Rochau2014 ER - TY - STD TI - IARC Press release World Cancer Day. 2008. p. 2. http://www.vr.se/download/18.2f62b054117692ac43f80008393/PM_IARC_cancer_080104.pdf. Accessed 21 Aug 2016. UR - http://www.vr.se/download/18.2f62b054117692ac43f80008393/PM_IARC_cancer_080104.pdf ID - ref8 ER - TY - STD TI - Cancer control, knowledge into action, WHO guide for effective programs. 2007. P.III. http://www.who.int/cancer/modules/Prevention%20Module.pdf. Accessed 21 Aug 2016. UR - http://www.who.int/cancer/modules/Prevention%20Module.pdf ID - ref9 ER - TY - JOUR AU - Lenfant, C. PY - 2003 DA - 2003// TI - Clinical Research to Clinical Practice - Lost in Translation? JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMsa035507 DO - 10.1056/NEJMsa035507 ID - Lenfant2003 ER - TY - JOUR AU - Hillner, B. F. AU - Smith, T. J. PY - 2009 DA - 2009// TI - Efficacy Does Not Necessarily Translate to Cost Effectiveness: A Case Study in the Challenges Associated With 21st-Century Cancer Drug Pricing JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.0534 DO - 10.1200/JCO.2008.21.0534 ID - Hillner2009 ER - TY - JOUR AU - Schneeweiss, A. AU - Chia, S. AU - Hickish, T. AU - Harvey, V. AU - Eniu, A. AU - Hegg, R. AU - Tausch, C. AU - Seo, J. H. AU - Tsai, Y. F. AU - Ratnayake, J. AU - McNally, V. AU - Ross, G. AU - Cortés, J. PY - 2013 DA - 2013// TI - Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt182 DO - 10.1093/annonc/mdt182 ID - Schneeweiss2013 ER - TY - STD TI - Israeli Social Security Report for Health Services in 2008. http://taubcenter.org.il/wp-content/files_mf/sept2010.pdf. Accessed 21 Aug 2016. UR - http://taubcenter.org.il/wp-content/files_mf/sept2010.pdf ID - ref13 ER - TY - JOUR AU - Drummond, M. F. AU - Mason, A. R. PY - 2007 DA - 2007// TI - European perspective on the costs and cost-effectiveness of cancer therapies JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.07.8956 DO - 10.1200/JCO.2006.07.8956 ID - Drummond2007 ER - TY - JOUR AU - Reeder, C. E. AU - Gordon, D. PY - 2006 DA - 2006// TI - Managing oncology costs JO - Am J Manag Care VL - 12 ID - Reeder2006 ER - TY - JOUR AU - Claxton, K. AU - Sculpher, M. AU - Drummond, M. PY - 2002 DA - 2002// TI - A rational framework for decision making by the National Institute For Clinical Excellence (NICE) JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)09832-X DO - 10.1016/S0140-6736(02)09832-X ID - Claxton2002 ER - TY - JOUR AU - McCabe, C. AU - Bergmann, L. AU - Bosanquet, N. AU - Ellis, M. AU - Enzmann, H. AU - Euler, M. AU - Jönsson, B. AU - Kallen, K. J. AU - Newling, D. AU - Nüssler, V. AU - Paschen, V. AU - Wilde, R. AU - Wilking, N. AU - Teale, C. AU - Zwierzina, H. PY - 2009 DA - 2009// TI - Biotherapy Development Association. Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn603 DO - 10.1093/annonc/mdn603 ID - McCabe2009 ER - TY - JOUR AU - Niezen, M. G. AU - Bont, A. AU - Stolk, E. AU - Eyck, A. AU - Niessen, L. AU - Stoevelaar, H. PY - 2007 DA - 2007// TI - Conditional reimbursement within the Dutch drug policy JO - Health Policy VL - 84 UR - https://doi.org/10.1016/j.healthpol.2006.11.005 DO - 10.1016/j.healthpol.2006.11.005 ID - Niezen2007 ER -